Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades3
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Share Price Information for Faron Pharmaceuticals (FARN)
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals Notes Study Supporting Clevegen Programme
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.
Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.
"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.
Shares in Faron were trading flat at 275.00 pence on Monday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Latest FARN News
- UK TRADING UPDATE SUMMARY: Churchill China Sales Hit By Virus
11 Jun 2020 - Faron Pharmaceuticals confirms publication of 'crucial' study
20 May 2020 - Faron Pharma Gets EUR800,000 Grant From Finnish Cancer Consortium
11 May 2020 - UK Shareholder Meetings Calendar - Next 7 Days
11 May 2020 - Faron Pharmaceuticals Picks Manufacturing Partner For Clevegen Therapy
5 May 2020 - Faron Pharmaceuticals inks manufacturing deal with AGC Biologics
5 May 2020 - UK EXECUTIVE CHANGE SUMMARY: Corero Hires Former CML Finance Director
27 Apr 2020 - UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing
27 Apr 2020
Related News
IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...
WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Faron Pharmaceuticals News
UK TRADING UPDATE SUMMARY: Churchill China Sales Hit By Virus
UK TRADING UPDATE SUMMARY: Churchill China Sales Hit By Virus
Faron Pharmaceuticals confirms publication of 'crucial' study
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Wednesday that the results of its detailed analyses int...
Faron Pharma Gets EUR800,000 Grant From Finnish Cancer Consortium
Faron Pharma Gets EUR800,000 Grant From Finnish Cancer Consortium
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Faron Pharmaceuticals Picks Manufacturing Partner For Clevegen Therapy
Faron Pharmaceuticals Picks Manufacturing Partner For Clevegen Therapy
Faron Pharmaceuticals inks manufacturing deal with AGC Biologics
(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals has selected contract development and manufacturing organisation AG...
UK EXECUTIVE CHANGE SUMMARY: Corero Hires Former CML Finance Director
UK EXECUTIVE CHANGE SUMMARY: Corero Hires Former CML Finance Director
UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing
UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing
Follow the stocks
